BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1632116)

  • 1. [Applicability of CCK receptor antagonists in physiologic and therapeutic studies].
    Heintges T; Niederau C
    Z Gastroenterol; 1992 May; 30(5):337-43. PubMed ID: 1632116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay.
    Liddle RA
    Gastroenterol Clin North Am; 1989 Dec; 18(4):735-56. PubMed ID: 2482253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of a new serine derivative cholecystokinin receptor antagonist TP-680 on pancreatic, biliary and gastric function.
    Tachibana I; Kanagawa K; Yamamoto Y; Otsuki M
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1404-12. PubMed ID: 8968365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic secretory response to feeding in the calf: CCK-A receptors, but not CCK-B/gastrin receptors are involved.
    Le Dréan G; Le Huërou-Luron I; Gestin M; Romé V; Bernard C; Chayvialle JA; Fourmy D; Guilloteau P
    Can J Physiol Pharmacol; 2000 Oct; 78(10):813-9. PubMed ID: 11077982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cholecystokinin on gastric motility in humans.
    Beglinger C
    Ann N Y Acad Sci; 1994 Mar; 713():219-25. PubMed ID: 8185162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCK1 antagonists: are they ready for clinical use?
    Peter SA; D'Amato M; Beglinger C
    Dig Dis; 2006; 24(1-2):70-82. PubMed ID: 16699265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder. Mechanisms of action.
    Behar J; Biancani P
    J Clin Invest; 1980 Dec; 66(6):1231-9. PubMed ID: 7440712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.
    Wang HH; Portincasa P; Wang DQ
    Curr Med Chem; 2019; 26(19):3407-3423. PubMed ID: 28625150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cholecystokinin in appetite control and body weight regulation.
    Little TJ; Horowitz M; Feinle-Bisset C
    Obes Rev; 2005 Nov; 6(4):297-306. PubMed ID: 16246215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study.
    Cremonini F; Camilleri M; McKinzie S; Carlson P; Camilleri CE; Burton D; Thomforde G; Urrutia R; Zinsmeister AR
    Am J Gastroenterol; 2005 Mar; 100(3):652-63. PubMed ID: 15743365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cholecystokinin in the gastric motor response to a meal in horses.
    Lorenzo-Figueras M; Merritt AM
    Am J Vet Res; 2006 Dec; 67(12):1998-2005. PubMed ID: 17144800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans.
    Cantor P; Mortensen PE; Myhre J; Gjorup I; Worning H; Stahl E; Survill TT
    Gastroenterology; 1992 May; 102(5):1742-51. PubMed ID: 1568584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in gastrointestinal hormones: cholecystokinin].
    Ubilluz R
    Rev Gastroenterol Peru; 1994; 14(3):222-32. PubMed ID: 8000026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCK/gastrin antagonists--clinical perspectives.
    Calam J
    Acta Gastroenterol Belg; 1993; 56(3-4):251-6. PubMed ID: 8266765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
    Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C
    Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of CCK on pancreatic function and morphology.
    Niederau C; Lüthen R; Heintges T
    Ann N Y Acad Sci; 1994 Mar; 713():180-98. PubMed ID: 8185159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of antagonists of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Jun; 42(2):195-209. PubMed ID: 1664265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rectal distension on gallbladder emptying and circulating gut hormones.
    van Hoek F; Mollen RM; Hopman WP; Kuijpers HH; Jansen JB
    Eur J Clin Invest; 2000 Nov; 30(11):988-94. PubMed ID: 11114961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.